A correlation of FTIR spectra derived from prostate cancer biopsies with gleason grade and tumour stage.

OBJECTIVES We introduce biochemistry as a second dimension to Gleason grading, using Fourier transform infrared (FTIR) microspectroscopy. For the first time, we correlate FTIR spectra derived from prostate cancer (pCA) tissue with Gleason score and the clinical stage of the tumour at time of biopsy. METHODS Serial sections from paraffin-embedded pCA tissue were collected. One was stained with hematoxylin and eosin and Gleason scored; FTIR spectra were collected from malignant locations using a second unstained section. FTIR spectra, representing different Gleason grades, were used to construct a diagnostic classifier for pCA using linear discriminant analysis (LDA). This model was blind tested using 383 IR spectra from 36 biopsies. RESULTS Using a three-band Gleason criteria, we obtained sensitivity of > or =70% for the FTIR-LDA model to predict Gleason <7,=7, and >7, with specificities of > or =81%. Using a threshold of Gleason/FTIR-LDA score of > or =8, we obtained a sensitivity and specificity of 71% and 67%, respectively, for the correlation with metastatic tumours using the FTIR-LDA system and 85% and 63%, respectively, for the correlation of metastatic tumours using the Gleason system. CONCLUSIONS There is a correlation between tissue architecture using Gleason score with tissue biochemistry using FTIR-LDA. Both systems are similar in their performance in predicting metastatic behaviour in tumours from individual patients.

[1]  Zhong Jiang,et al.  Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. , 2005, American journal of clinical pathology.

[2]  N Stone,et al.  The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro , 2003, British Journal of Cancer.

[3]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[4]  F. Mostofi,et al.  p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy. , 1999, The Journal of urology.

[5]  I. W. Levin,et al.  Fourier transform infrared vibrational spectroscopic imaging: integrating microscopy and molecular recognition. , 2005, Annual review of physical chemistry.

[6]  F. Saad,et al.  Gleason score on biopsy: is it reliable for predicting the final grade on pathology? , 2002, BJU international.

[7]  C. Roehrborn,et al.  Gleason score predicts androgen independent progression after androgen deprivation therapy. , 2002, European urology.

[8]  A. V. von Eschenbach,et al.  Prognostic factors for clinically localized prostate carcinoma , 1997, Cancer.

[9]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.

[10]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .

[11]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[12]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Layfield,et al.  Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage? , 1997, The Journal of urology.

[14]  N. Polissar,et al.  Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Daniel Birnbaum,et al.  DNA Arrays in Clinical Oncology: Promises and Challenges , 2003, Laboratory Investigation.

[16]  S. Hewitt,et al.  Infrared spectroscopic imaging for histopathologic recognition , 2005, Nature Biotechnology.

[17]  Jaleel A. Miyan,et al.  The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer. , 2004, Faraday discussions.

[18]  D. Gleason,et al.  Histologic Grading and Staging of Prostatic Carcinoma , 1981 .

[19]  J. Oesterling,et al.  Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. , 1987, The Journal of urology.

[20]  H. Frierson,et al.  Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years , 2002, Cancer.

[21]  J Dwyer,et al.  Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study , 2003, The Journal of pathology.